Sacral Neuromodulation & Urodynamics

Universiteit Antwerpen100 enrolled

Overview

In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR). Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Overactive Bladder Non-obstructive Urinary Retention

Interventions

urodynamicsDIAGNOSTIC_TEST

Bladder filling and pressure is measured by the insertion of probes within the bladder, urethra and anorectum.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Overactive bladder * Non-obstructive urinary retention Exclusion Criteria: * Neurogenica disorder (e.g. cerebrovascular accident, spinal cord injury)

Locations (1)

University of antwerp

Antwerp, Edegem, Belgium

RECRUITING

Outcomes

Primary Outcomes

Change in bladder volume

Change in bladder volume is measured before and after test procedure for sacral neuromodulation

Time frame: 3 weeks

Change in bladder sensation

Bladder sensation is measured by a slider (indicating bladder fullness scaled from 0 to 100) before and after test procedure for sacral neuromodulation

Time frame: 3 weeks

Change in ice water test

Ice water is infused in the bladder and incontinence upon insertion of the ice water is assessed before and after sacral neuromodulation

Time frame: 3 weeks

Central Contacts

Stefan De Wachter, MD PhD FEBU

CONTACT

8215934 stefan.dewachter@antwerpen.be

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.